Aspen Aerogels schedules third-quarter results. USD 80 million guide frames Aspen Aerogels stock

Published on 10/28/2026 at 06:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results for Aspen Aerogels stock arrive November 5, 2026. Q2 revenue was USD 49.80 million against USD 65.00-80.00 million guidance.

Results date and operating guide

Aspen Aerogels scheduled its third-quarter release for November 5, 2026, before the market opens.
Second-quarter revenue reached USD 49.80 million, while third-quarter guidance spans USD 65.00 million to USD 80.00 million.
Aspen Aerogels stock had a market capitalization of USD 447.3 million as of October 27, 2026.

ASPN, US04523Y1055, Illustration mit AI erstellt.

Aspen Aerogels (ISIN US04523Y1055) scheduled its third-quarter results for November 5, 2026, before the market opens. According to GlobeNewswire, the company will discuss results for the quarter ended September 30, 2026, during a conference call at 8:30 a.m. ET.

Guidance sets the earnings test

Aspen Aerogels entered the report date with third-quarter revenue guidance of USD 65.00 million to USD 80.00 million and adjusted EBITDA guidance of USD 7.00 million to USD 15.00 million. The upper revenue guide is USD 30.20 million above second-quarter revenue of USD 49.80 million, a sequential increase of 60.64 percent, based on figures reported by Tickeron.

The same guidance also points to a possible operating improvement. Adjusted EBITDA was negative USD 6.60 million in the second quarter, while management projected a positive USD 7.00 million to USD 15.00 million for the third quarter, according to Tickeron.

What does the timeline mean?

The November 5 release is the next scheduled company date. The announcement covers both the financial release before the market opens and the conference call at 8:30 a.m. ET, giving investors two closely linked checkpoints for revenue, margin and production commentary.

Three events shape the recovery

On August 6, 2026, Aspen Aerogels reported second-quarter revenue of USD 49.80 million and issued the third-quarter revenue guide of USD 65.00 million to USD 80.00 million. On August 7, 2026, B. Riley raised its price target from USD 7.00 to USD 9.00 while maintaining a Buy rating, as listed by MarketScreener. On October 22, 2026, the company announced the November 5 reporting date through GlobeNewswire.

Market value before the release

Aspen Aerogels had a market capitalization of USD 447.3 million as of October 27, 2026. Its 52-week range was USD 2.30 to USD 8.56 on the same date, leaving the scheduled results as the next dated test of whether the revenue guide can translate into positive adjusted EBITDA.